

SUrrogate markers for Micro- and Macro-vascular hard endpoints for Innovative diabetes Tools

Achievements
Eye on it:
SUMMIT delivers and reports back on its achievements
|
||
|
|
|
MISSION
To DISCOVER, DEVELOP and QUALIFY potential MARKERS that empower:
-
the identification of patients at high risk of diabetes complications
-
the monitoring of the complications' progression and patients‘ response to therapy
To use the discovered markers as SURROGATE ENDPOINTS in clinical trials.
Thereby, SHORTEN the long lasting CLINICAL TRIALS to bring about EARLIER availability of NEW THERAPY to diabetic patients.